Media

Nordic Nanovector to Present at Upcoming Deutsche Bank and Jefferies Healthcare Conferences

GenSight Biologics to Present GS010 at the 4th Annual Retinal Cell & Gene Therapy Innovation Summit

Onxeo: Q1 2017 financial information and business update

PharmAthene and Altimmune Announce Combined Company Approved for Trading on Nasdaq Global Market

GenSight Biologics reports its cash position as of March 31, 2017

Wilson Therapeutics presents promising neurological Phase 2 data for WTX101 at AAN meeting

Aarhus University Hospital in Denmark Purchases NBS System from Nexstim Plc

Wilson Therapeutics presented positive final Phase 2 data for WTX101 at EASL Annual Meeting

Clinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)